| Bone mass and strength are significantly improved in mice overexpressing human WNT16 in osteocytes I Alam, AM Reilly, M Alkhouli, RL Gerard-O’Riley, C Kasipathi, DK Oakes, ... Calcified tissue international 100, 361-373, 2017 | 18 | 2017 |
| Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease I Alam, AK McQueen, D Acton, AM Reilly, RL Gerard-O'Riley, DK Oakes, ... Bone 94, 34-41, 2017 | 17 | 2017 |
| Overexpression of WNT16 does not prevent cortical bone loss due to glucocorticoid treatment in mice I Alam, DK Oakes, AM Reilly, C Billingsley, S Sbeta, RL Gerard‐O'Riley, ... JBMR plus 3 (4), e10084, 2019 | 11 | 2019 |
| Overexpression of WNT16 does not Rescue the Bone Loss due to Glucocorticoid Treatment in Mice. I Alam, D Oakes, S Sbeta, C Billingsley, D Acton, A Reilly, ... Journal of Bone and Mineral Research 32, S370-S370, 2017 | 3 | 2017 |
| Bone Marrow Transplantation as a Therapy for Autosomal Dominant Osteopetrosis Type II in Mice I Alam, E Imel, R Gerard-O'Riley, D Acton, D Oakes, M Alvarez, M Kacena, ... JOURNAL OF BONE AND MINERAL RESEARCH 33, 303-303, 2018 | | 2018 |
